| Financial Year |
March 31 2023 |
| Monetary Funds |
2,491,636,136.31 |
| Held-for-trading Financial Assets |
311,245,972.61 |
| Notes Receivable |
-- |
| Accounts Receivable |
329,835,803.48 |
| Advances to Suppliers |
316,787,132.98 |
| Other Receivables |
25,182,538.35 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
591,731,893.32 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
17,320,203.37 |
| Total Current Assets |
4,106,276,377.67 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
17,887,926.74 |
| Investment Properties |
87,777,057.38 |
| Fixed Assetes |
1,005,908,549.68 |
| Under-construction Projects |
267,337,983.56 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
369,598,413.06 |
| R&D expenses |
-- |
| Goodwill |
1,206,718,611.95 |
| Long-Term Deferred and Prepaid Expenses |
38,575,196.16 |
| Deferred Income Tax Assets |
30,251,605.59 |
| Other Non-Current Assets |
128,530,806.58 |
| Sub-Total of Non-Current Assets |
3,658,679,914.88 |
| Total Assets |
7,764,956,292.55 |
| Short-Term Loans |
1,595,929,196.74 |
| Trading Financial liabilities |
-- |
| Notes Payable |
286,504,436.35 |
| Accounts Payable |
352,907,637.21 |
| Accounts Received In Advance |
324,770.64 |
| Employee Compensation Payable |
29,366,872.12 |
| Taxes Payable |
37,469,269.69 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
84,337,363.88 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
61,565,625.95 |
| Other Current Liabilities |
3,447,574.86 |
| Sub-Total of Current Liabilities |
2,487,948,802.90 |
| Long-term Loans |
207,635,741.46 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
271,380,293.08 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
10,156,762.14 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
641,807,064.55 |
| Total Liabilities |
3,129,755,867.45 |
| Paid-In Capital(Or Share Stock) |
1,235,983,020.00 |
| Capital Surplus |
3,261,861,616.41 |
| Surplus Reserve |
91,381,553.35 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-32,753,927.17 |
| Minority Stockholder's Interest |
78,888,978.08 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,556,311,447.02 |
| Owner's Equity（Stockholder's Equity） |
4,635,200,425.10 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,764,956,292.55 |
